Free Trial
NASDAQ:XRAY

DENTSPLY SIRONA (XRAY) Stock Price, News & Analysis

DENTSPLY SIRONA logo
$18.28 +0.41 (+2.29%)
(As of 11/15/2024 ET)

About DENTSPLY SIRONA Stock (NASDAQ:XRAY)

Key Stats

Today's Range
$17.73
$18.47
50-Day Range
$17.26
$27.06
52-Week Range
$17.21
$37.60
Volume
4.19 million shs
Average Volume
4.57 million shs
Market Capitalization
$3.63 billion
P/E Ratio
N/A
Dividend Yield
3.50%
Price Target
$29.50
Consensus Rating
Hold

Company Overview

DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform. It also provides endodontic products consisting of motorized endodontic handpieces, files, sealers, irrigation needles, and other tools that support root canal procedures; restorative products, including dental ceramics, crowns, and veneers; and preventative products, such as curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, and impression materials. In addition, the company offers SureSmile and Byte aligner solutions; VPro/HyperByte, a high-frequency vibration technology device; SureSmile Simulator, which creates a 3D visualization of a patient's outcome; and Byte Plus for treatment planning. Further, it provides dental implants, digital dentures, crown and bridge porcelain products, bone regenerative and restorative solutions, treatment planning software, and educational programs; dental prosthetics; urology catheters; and other health-related consumables. The company serves professional dental and consumable medical device markets through third-party distributors. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina

DENTSPLY SIRONA Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
98th Percentile Overall Score

XRAY MarketRank™: 

DENTSPLY SIRONA scored higher than 98% of companies evaluated by MarketBeat, and ranked 37th out of 971 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    DENTSPLY SIRONA has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 3 buy ratings, 6 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    DENTSPLY SIRONA has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about DENTSPLY SIRONA's stock forecast and price target.
  • Earnings Growth

    Earnings for DENTSPLY SIRONA are expected to grow by 7.07% in the coming year, from $1.84 to $1.97 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of DENTSPLY SIRONA is -8.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of DENTSPLY SIRONA is -8.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    DENTSPLY SIRONA has a PEG Ratio of 1.76. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    DENTSPLY SIRONA has a P/B Ratio of 1.46. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about DENTSPLY SIRONA's valuation and earnings.
  • Percentage of Shares Shorted

    6.98% of the float of DENTSPLY SIRONA has been sold short.
  • Short Interest Ratio / Days to Cover

    DENTSPLY SIRONA has a short interest ratio ("days to cover") of 4.6.
  • Change versus previous month

    Short interest in DENTSPLY SIRONA has recently decreased by 15.78%, indicating that investor sentiment is improving significantly.
  • Dividend Leadership

    DENTSPLY SIRONA is a leading dividend payer. It pays a dividend yield of 3.58%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    DENTSPLY SIRONA has been increasing its dividend for 13 years.

  • Dividend Sustainability

    Based on earnings estimates, DENTSPLY SIRONA will have a dividend payout ratio of 32.49% next year. This indicates that DENTSPLY SIRONA will be able to sustain or increase its dividend.

  • Read more about DENTSPLY SIRONA's dividend.
  • Percentage of Shares Shorted

    6.98% of the float of DENTSPLY SIRONA has been sold short.
  • Short Interest Ratio / Days to Cover

    DENTSPLY SIRONA has a short interest ratio ("days to cover") of 4.6.
  • Change versus previous month

    Short interest in DENTSPLY SIRONA has recently decreased by 15.78%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    DENTSPLY SIRONA has a news sentiment score of -0.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 25 news articles for DENTSPLY SIRONA this week, compared to 6 articles on an average week.
  • Search Interest

    6 people have searched for XRAY on MarketBeat in the last 30 days. This is an increase of 500% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added DENTSPLY SIRONA to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, DENTSPLY SIRONA insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.52% of the stock of DENTSPLY SIRONA is held by insiders.

  • Percentage Held by Institutions

    95.70% of the stock of DENTSPLY SIRONA is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about DENTSPLY SIRONA's insider trading history.
Receive XRAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DENTSPLY SIRONA and its competitors with MarketBeat's FREE daily newsletter.

XRAY Stock News Headlines

Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?
Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?
Q1 EPS Estimate for DENTSPLY SIRONA Reduced by Analyst
William Blair Expects Weaker Earnings for DENTSPLY SIRONA
Stifel Nicolaus Remains a Hold on DENTSPLY SIRONA (XRAY)
See More Headlines

XRAY Stock Analysis - Frequently Asked Questions

DENTSPLY SIRONA's stock was trading at $35.59 on January 1st, 2024. Since then, XRAY shares have decreased by 48.6% and is now trading at $18.28.
View the best growth stocks for 2024 here
.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) released its quarterly earnings data on Thursday, November, 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.02. The business's revenue for the quarter was up .4% on a year-over-year basis.
Read the conference call transcript
.

DENTSPLY SIRONA's board authorized a stock repurchase program on Thursday, November 9th 2023, which allows the company to buy back $1,000,000,000 in outstanding shares, according to EventVestor. This means that the company could purchase up to 16.9% of its shares through open market purchases. Shares repurchase programs are often an indication that the company's leadership believes its shares are undervalued.

DENTSPLY SIRONA subsidiaries include these companies: Propel Orthodontics LLC, Datum Dental Ltd., Straight Smile LLC, OraMetrix Inc, Recherche Techniques Dentaires, MIS Implants Technologies Ltd, Sirona Dental System, and others.

Top institutional investors of DENTSPLY SIRONA include Nuance Investments LLC (5.35%), FMR LLC (4.56%), State Street Corp (3.25%) and Janus Henderson Group PLC (3.21%). Insiders that own company stock include Cord Friedrich Staehler, Glenn Coleman, Gregory T Lucier, Eric Brandt, Donald M Jr Casey, Lisa Yankie and Walter Petersohn.
View institutional ownership trends
.

Shares of XRAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that DENTSPLY SIRONA investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Exxon Mobil (XOM).

Company Calendar

Ex-Dividend for 10/11 Dividend
9/27/2024
Dividend Payable
10/11/2024
Last Earnings
11/07/2024
Today
11/16/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
3/06/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Dental equipment & supplies
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:XRAY
CUSIP
24903010
Employees
15,000
Year Founded
1899

Price Target and Rating

Average Stock Price Target
$29.50
High Stock Price Target
$42.00
Low Stock Price Target
$24.00
Potential Upside/Downside
+61.4%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
9 Analysts

Profitability

Net Income
$-132,000,000.00
Pretax Margin
-9.13%

Debt

Sales & Book Value

Annual Sales
$3.90 billion
Cash Flow
$4.94 per share
Book Value
$12.53 per share

Miscellaneous

Free Float
197,746,000
Market Cap
$3.63 billion
Optionable
Optionable
Beta
1.02

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:XRAY) was last updated on 11/16/2024 by MarketBeat.com Staff
From Our Partners